A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied

A Non-Lipolysis Nanoemulsion Improved Oral Bioavailability by Reducing the First-Pass Metabolism of Raloxifene, and Related Absorption Mechanisms Being Studied

Jing-Yi Ye,1 Zhong-Yun Chen,1 Chuan-Li Huang,1 Bei Huang,2 Yu-Rong Zheng,2 Ying-Feng Zhang,1 Ban-Yi Lu,2 Lin He,2 Chang-Shun Liu3 ,* Xiao-Ying Long1,4, * 1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, People’s Republic of China; 2School of Chinese Medicine, Gua...

Full description

Bibliographic Details
Main Authors: Ye JY, Chen ZY, Huang CL, Huang B, Zheng YR, Zhang YF, Lu BY, He L, Liu CS, Long XY
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:International Journal of Nanomedicine
Subjects:
non-lipolysis nanoemulsion
raloxifene
first-pass metabolism
stability
bioavailability
endocytosis
Online Access:https://www.dovepress.com/a-non-lipolysis-nanoemulsion-improved-oral-bioavailability-by-reducing-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/a-non-lipolysis-nanoemulsion-improved-oral-bioavailability-by-reducing-peer-reviewed-article-IJN

Similar Items